Peter Brendon Johnston - Net Worth and Insider Trading
Peter Brendon Johnston Net Worth
The estimated net worth of Peter Brendon Johnston is at least $16 Million dollars as of 2024-09-24. Peter Brendon Johnston is the Director of Knight Therapeutics Inc and owns about 2,750,000 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $16 Million. Details can be seen in Peter Brendon Johnston's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Brendon Johnston has not made any transactions after 2019-07-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter Brendon Johnston
Peter Brendon Johnston Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Brendon Johnston owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Peter Brendon Johnston’s form 4 insider trades.
Insider Ownership Summary of Peter Brendon Johnston
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-07-25 | Director |
Peter Brendon Johnston Latest Holdings Summary
Peter Brendon Johnston currently owns a total of 1 stock. Peter Brendon Johnston owns 2,750,000 shares of Knight Therapeutics Inc (TSX:GUD) as of July 25, 2019, with a value of $16 Million.
Latest Holdings of Peter Brendon Johnston
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-07-25 | 2,750,000 | 5.91 | 16,252,500 |
Holding Weightings of Peter Brendon Johnston
Peter Brendon Johnston Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Brendon Johnston has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the acquisition of 2,500,000 shares on July 25, 2019, which cost Peter Brendon Johnston around $19 Million.
Insider Trading History of Peter Brendon Johnston
- 1
Peter Brendon Johnston Trading Performance
GuruFocus tracks the stock performance after each of Peter Brendon Johnston's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Brendon Johnston is 13.29%. GuruFocus also compares Peter Brendon Johnston's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Brendon Johnston within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter Brendon Johnston's insider trading performs compared to the benchmark.
Performance of Peter Brendon Johnston
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.09 | | | | | |
| Relative Return to S&P 500(%) | 8.3 | | | | | |
Peter Brendon Johnston Ownership Network
Peter Brendon Johnston Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Peter Brendon Johnston is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Peter Brendon Johnston made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Peter Brendon Johnston Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Brendon Johnston. Currently GuruFocus does not have mailing address information for Peter Brendon Johnston.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
